Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
Eur J Clin Microbiol Infect Dis
    October 2026
  1. KISA O
    Current laboratory diagnostics for tuberculosis: from conventional approaches to next-generation molecular and immunological technologies.
    Eur J Clin Microbiol Infect Dis. 2026 Oct 6. doi: 10.1007/s10096-026-05688.
    >> Share

    September 2026
  2. LI XJ, Zhang N, Zhang Q, Chen R, et al
    HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.
    Eur J Clin Microbiol Infect Dis. 2026 Sep 29. doi: 10.1007/s10096-026-05686.
    >> Share

  3. RIPOLL JJ, Clari MA, Orta N, Chouman R, et al
    Clinical performance of the Abbott RealTime Mycobacterium tuberculosis (MTB) PCR on bronchoscopic specimens for diagnosing pulmonary tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2026 Sep 9. doi: 10.1007/s10096-026-05652.
    >> Share

  4. LI Q, Yang X, Zhu H, Yang S, et al
    A rare case of long-standing lupus vulgaris with psoriasiform manifestations diagnosed by mNGS: a case report.
    Eur J Clin Microbiol Infect Dis. 2026;45:2891-2893.
    >> Share

    August 2026
  5. LEE JM, Kim HW, Lee EG, Park Y, et al
    Real-world treatment outcomes of a 6-month fluoroquinolone-containing regimen for isoniazid mono-resistant pulmonary tuberculosis in Korea.
    Eur J Clin Microbiol Infect Dis. 2026 Aug 13. doi: 10.1007/s10096-026-05629.
    >> Share

    July 2026
  6. SEPULCRI C, Crupi L, Delfino E, Taramasso L, et al
    Prevalence, risk factors, clinical characteristics and outcomes of tuberculosis-associated immune reconstitution inflammatory syndrome in a HIV and tuberculosis low-incidence setting.
    Eur J Clin Microbiol Infect Dis. 2026 Jul 27. doi: 10.1007/s10096-026-05609.
    >> Share

    June 2026
  7. GIJON P, Aldamiz T, Ramos-Lisbona AI, Valenzuela F, et al
    Breaking barriers: Implementation of a tuberculosis preventive treatment protocol among newly eligible populations with promising results.
    Eur J Clin Microbiol Infect Dis. 2026 Jun 30. doi: 10.1007/s10096-026-05570.
    >> Share

  8. GAO X, Qin R, Li S, Yang Y, et al
    Congenital tuberculosis transmitted via the placenta: identification by metagenomic next-generation sequencing.
    Eur J Clin Microbiol Infect Dis. 2026 Jun 6. doi: 10.1007/s10096-026-05564.
    >> Share

    April 2026
  9. ZHAN S, Pang K, Li X, Yang L, et al
    Contezolid in tuberculosis therapy: a retrospective analysis of real-world practice in China.
    Eur J Clin Microbiol Infect Dis. 2026 Apr 10. doi: 10.1007/s10096-026-05503.
    >> Share

    March 2026
  10. FU Y, Jiao F, Yang X, Wang Y, et al
    Clinical characteristics and risk factors of severe pulmonary tuberculosis in children in Yunnan, China.
    Eur J Clin Microbiol Infect Dis. 2026 Mar 21. doi: 10.1007/s10096-026-05467.
    >> Share

  11. FEUTH T, Rajalahti I, Vauhkonen M, Nordstrand K, et al
    Screening and treatment practices for tuberculosis infection in Nordic, Baltic and Central European countries and Ukraine in 2023.
    Eur J Clin Microbiol Infect Dis. 2026 Mar 18. doi: 10.1007/s10096-026-05471.
    >> Share

  12. ERGIN BB, Ekuklu G
    Drug resistance trends in Tuberculosis cases: Insights from a decade of surveillance data.
    Eur J Clin Microbiol Infect Dis. 2026 Mar 17. doi: 10.1007/s10096-026-05466.
    >> Share

  13. DUDNYK A, Tytarenko N, Andrada IR, Lytvyniuk O, et al
    Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study.
    Eur J Clin Microbiol Infect Dis. 2026 Mar 6. doi: 10.1007/s10096-026-05451.
    >> Share

    February 2026
  14. ZHOU X, Tang N, Liao X, Bao X, et al
    The diagnostic yield of brushing versus non-brushing bronchoalveolar lavage fluid for Xpert MTB/RIF in patients with suspected tuberculosis: a prospective self-controlled study.
    Eur J Clin Microbiol Infect Dis. 2026 Feb 13. doi: 10.1007/s10096-026-05435.
    >> Share

    January 2026
  15. GUPTA RK, Chauhan K, Singhal R, Anthwal D, et al
    Development and evaluation of 'Quick TB DNA Extraction' kit for the rapid and efficient detection of multidrug-resistant tuberculosis from sputum transported on bio-safe filter.
    Eur J Clin Microbiol Infect Dis. 2026 Jan 12. doi: 10.1007/s10096-025-05312.
    >> Share

  16. PU J, Wu S, He JQ
    High dose of rifampicin in the treatment of tuberculous meningitis: a systematic review and meta-analysis of randomized controlled trials.
    Eur J Clin Microbiol Infect Dis. 2026 Jan 9. doi: 10.1007/s10096-025-05364.
    >> Share

    December 2025
  17. QIU C, Zhou GF, Li GB, Ao J, et al
    Establishing a clinical tool to predict acute kidney injury in pulmonary tuberculosis: insights from a large-scale retrospective study.
    Eur J Clin Microbiol Infect Dis. 2025 Dec 30. doi: 10.1007/s10096-025-05382.
    >> Share

  18. ROTUNDO S, Serapide F, Guido G, Di Gennaro F, et al
    Is the unavailability of rifapentine holding back the end TB strategy in Europe? Implication for tuberculosis control among migrants and refugees.
    Eur J Clin Microbiol Infect Dis. 2025 Dec 16. doi: 10.1007/s10096-025-05304.
    >> Share

    October 2025
  19. KIM Y, Lee DG, Bae J, Jung J, et al
    Characteristic exploration of Mycobacterium tuberculosis isolated from patients with linezolid-treated multidrug-resistant tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2025 Oct 29. doi: 10.1007/s10096-025-05319.
    >> Share

  20. ROTUNDO S, Serapide F, d'Ettorre G, Tassone MT, et al
    Managing tuberculosis infection among migrants from high-incidence tuberculosis countries: challenges, strategies and recommendations.
    Eur J Clin Microbiol Infect Dis. 2025 Oct 9. doi: 10.1007/s10096-025-05301.
    >> Share

    July 2025
  21. JAIN B, Kulkarni S, Baghel NS
    Rapid screening of mutations for second-line-drug-resistant genes in Mycobacterium tuberculosis culture isolates by in-house developed DNA bio-chip.
    Eur J Clin Microbiol Infect Dis. 2025 Jul 29. doi: 10.1007/s10096-025-05221.
    >> Share

  22. YIGCI D, Kayi I, Demiroglu YZ, Kutlu M, et al
    Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress.
    Eur J Clin Microbiol Infect Dis. 2025 Jul 15. doi: 10.1007/s10096-025-05201.
    >> Share

  23. GUO S, Zhang Z, Perez AA, Xianyu F, et al
    Effectiveness of centralized hospitalization treatment on transmission in household contacts of pulmonary tuberculosis patients: a contact-traced study.
    Eur J Clin Microbiol Infect Dis. 2025 Jul 3. doi: 10.1007/s10096-025-05170.
    >> Share

  24. CARVALHO BT, Meirinhos SV, Domingos GJ, Peixoto S, et al
    Unseen but unforgettable - refractive bacilli in the gram stain of a muscular abscess.
    Eur J Clin Microbiol Infect Dis. 2025;44:1749-1752.
    >> Share

    May 2025
  25. MALHOTRA AG, Lokhande L, Pakhare A, Soni P, et al
    Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB).
    Eur J Clin Microbiol Infect Dis. 2025 May 31. doi: 10.1007/s10096-025-05177.
    >> Share

  26. FEI ZT, Zhou DP, Huang W, Liu P, et al
    Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections.
    Eur J Clin Microbiol Infect Dis. 2025 May 9. doi: 10.1007/s10096-025-05151.
    >> Share

    April 2025
  27. DING W, Shen L, Li R, Yang X, et al
    Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 9. doi: 10.1007/s10096-025-05128.
    >> Share

    March 2025
  28. QUAN DH, Wang T, Martinez E, Kim HY, et al
    Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2025 Mar 6. doi: 10.1007/s10096-025-05062.
    >> Share

    January 2025
  29. WANG MQ, Zheng YF, Hu YQ, Huang JX, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra for detecting pulmonary tuberculosis and rifampicin resistance: a systematic review and meta-analysis.
    Eur J Clin Microbiol Infect Dis. 2025 Jan 4. doi: 10.1007/s10096-024-05032.
    >> Share

    August 2024
  30. TURAN H, Gunak F, Yasaci Z, Ethemoglu G, et al
    Impact of the COVID-19 pandemic and migration on tuberculosis notifications: a retrospective analysis with 5-year data from three centers.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 7. doi: 10.1007/s10096-024-04918.
    >> Share

  31. ZHANG W, Xu J, Zhang L, Ni T, et al
    The value of histopathologic examination and Xpert (MTB/RIF) assay in diagnosis of cervical lymph node tuberculosis after coarse needle biopsy guided by CEUS: a retrospective analysis of 612 cases.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 1. doi: 10.1007/s10096-024-04913.
    >> Share

    July 2024
  32. FERRER J, Gimenez E, Carretero D, Clari MA, et al
    Abbott realtime MTB assay for detecting Mycobacterium tuberculosis complex in respiratory specimens: a cost-benefit analysis.
    Eur J Clin Microbiol Infect Dis. 2024 Jul 3. doi: 10.1007/s10096-024-04880.
    >> Share

    June 2024
  33. WEN R, Xiao J, Ding N, Zhong Y, et al
    Suitability of reduced dose glucocorticoids therapy regimen for antibody-associated vasculitis patients with TB: a retrospective study.
    Eur J Clin Microbiol Infect Dis. 2024;43:1061-1072.
    >> Share

    April 2024
  34. CHEN Y, Liu J, Zhang Q, Chen H, et al
    Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
    Eur J Clin Microbiol Infect Dis. 2024;43:747-765.
    >> Share

    February 2024
  35. CAO X, Guo T, Xin H, Du J, et al
    Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 22. doi: 10.1007/s10096-024-04777.
    >> Share

    January 2024
  36. ACHEAMPONG I, Minadzi D, Laing EF, Frimpong M, et al
    Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2024 Jan 3. doi: 10.1007/s10096-023-04741.
    >> Share

    December 2023
  37. SUN H, Ma Z, Ai F, Han B, et al
    Insidious transmission of Mycobacterium tuberculosis in Ordos, China: a molecular epidemiology study.
    Eur J Clin Microbiol Infect Dis. 2023 Dec 6. doi: 10.1007/s10096-023-04730.
    >> Share

  38. QUAN Z, Li M, Chen Y, Liang J, et al
    Performance evaluation of core genome multilocus sequence typing for genotyping of Mycobacterium tuberculosis strains in China: based on multicenter, population-based collection.
    Eur J Clin Microbiol Infect Dis. 2023 Dec 2. doi: 10.1007/s10096-023-04720.
    >> Share

    November 2023
  39. OU X, Song Z, Zhao B, Pei S, et al
    Diagnostic efficacy of an optimized nucleotide MALDI-TOF-MS assay for anti-tuberculosis drug resistance detection.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 18. doi: 10.1007/s10096-023-04700.
    >> Share

  40. PINHATA JMW, Ferrazoli L, Mendes FF, Goncalves MG, et al
    A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 9. doi: 10.1007/s10096-023-04693.
    >> Share

    September 2023
  41. NAGDEV PK, Agnivesh PK, Roy A, Sau S, et al
    Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection.
    Eur J Clin Microbiol Infect Dis. 2023 Sep 23. doi: 10.1007/s10096-023-04663.
    >> Share

    July 2023
  42. MEI ZX, Han JF, Yu HW, Zhang Y, et al
    Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2023 Jul 16. doi: 10.1007/s10096-023-04637.
    >> Share

    June 2023
  43. TANOGLU A, Erdem H, Friedland JS, Ankarali H, et al
    Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study.
    Eur J Clin Microbiol Infect Dis. 2023 Jun 15. doi: 10.1007/s10096-023-04630.
    >> Share

    May 2023
  44. LIU Y, Ren W, Xue Z, Miao Y, et al
    Real-time recombinase-aided amplification assay for rapid amplification of the IS1081 gene of Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2023 May 31. doi: 10.1007/s10096-023-04626.
    >> Share

  45. CASTRO-LIMA VAC, Santos APT, Musqueira PT, Maluf NZ, et al
    Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.
    Eur J Clin Microbiol Infect Dis. 2023 May 1. doi: 10.1007/s10096-023-04613.
    >> Share

    April 2023
  46. YEZLI S, Yassin Y, Mushi A, Maashi F, et al
    Undiagnosed and missed active pulmonary tuberculosis during mass gatherings: a prospective cross-sectional study from the Hajj pilgrimage.
    Eur J Clin Microbiol Infect Dis. 2023.
    >> Share

    February 2023
  47. YANG L, Xiang F, Wang D, Guo Q, et al
    The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016